The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses
The diagnosis of invasive aspergillosis in hematologic patients is a complex composite of clinical preconditions and features, imaging findings, biomarker combinations from appropriate clinical samples and microbiological and/or histological findings. Recent developments in the evolving landscape of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017/12/01
|
| In: |
Current opinion in infectious diseases
Year: 2017, Volume: 30, Issue: 6, Pages: 539-544 |
| ISSN: | 1473-6527 |
| DOI: | 10.1097/QCO.0000000000000408 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1097/QCO.0000000000000408 Verlag, Volltext: https://insights.ovid.com/crossref?an=00001432-201712000-00005 
|
| Author Notes: | Dieter Buchheidt, Mark Reinwald, Martin Hoenigl, Wolf-karsten Hofmann, Birgit Spiess, and Tobias Boch |
| Summary: | The diagnosis of invasive aspergillosis in hematologic patients is a complex composite of clinical preconditions and features, imaging findings, biomarker combinations from appropriate clinical samples and microbiological and/or histological findings. Recent developments in the evolving landscape of diagnostic tests for invasive aspergillosis in adult hematology patients are highlighted. Novel approaches and tools are currently under development. Focusing optimized diagnostic performance, in particular the combination of biomarkers from appropriate clinical samples, improved diagnostic performance distinctly. |
|---|---|
| Item Description: | Gesehen am 16.05.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1473-6527 |
| DOI: | 10.1097/QCO.0000000000000408 |